Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046436 · ClinicalTrials.gov registry record
Rapid HIV Tests for Women Late in Pregnancy and During Labor
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Terminated
- Registry status
- 7,500
- Enrollment target
NCT00046436: Clinical Trial study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00046436 is a clinical trial that was terminated before completion, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 7,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00046436 was terminated before completion, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- TERMINATED
- Registry status
- 7,500 participants
- Enrollment target
Study Summary
This study will look at how well the OraQuick HIV 1/2 Antibody rapid test works and how women accept being tested for HIV late in pregnancy and during labor. For women with positive test results, the study will look at whether or not these women accept anti-HIV drugs and which drugs they receive.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,500 participants |
| Est. Completion | 2004-03 |
Why NCT00046436 stopped before completion
NCT00046436 is an observational study that tracks outcomes without assigning an intervention. Its 7,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00046436 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00046436 about?
NCT00046436 is a clinical study titled "Rapid HIV Tests for Women Late in Pregnancy and During Labor". This study will look at how well the OraQuick HIV 1/2 Antibody rapid test works and how women accept being tested for HIV late in pregnancy and during labor. For women with positive test results, the study will look at whether or not these women accept anti-HIV drugs and which drugs they receive.
What is the current status of trial NCT00046436?
This trial is currently terminated. The enrollment target is 7,500 participants. Estimated completion is 2004-03.
Who is sponsoring clinical trial NCT00046436?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
- NCT05199701 · 7,500 participants · NA
Prospective Case Collection Study for New Mammography Technologies
- NCT06112418 · 7,500 participants · NA
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events